Valuation: ICU Medical, Inc.

Market Cap 4.16B 3.73B 3.45B 3.13B 5.84B 396B 5.91B 41.27B 16.44B 207B 15.61B 15.28B 658B P/E 2026 *
49.5x
P/E 2027 * 42.4x
Enterprise Value 4.92B 4.41B 4.08B 3.69B 6.9B 468B 6.98B 48.76B 19.42B 245B 18.45B 18.06B 778B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.07x
Free-Float
97.54%
Yield 2026 *
-
Yield 2027 * -
1 day+1.95%
1 week+3.45%
Current month+3.66%
1 month+1.44%
3 months+0.37%
6 months+37.50%
Current year+16.63%
1 week 157.63
Extreme 157.63
168.48
1 month 153.33
Extreme 153.33
168.62
Current year 113.37
Extreme 113.37
192.85
1 year 113.37
Extreme 113.37
192.85
3 years 78.28
Extreme 78.28
196.26
5 years 78.28
Extreme 78.28
251.77
10 years 78.28
Extreme 78.28
321.7
Manager TitleAgeSince
Chief Executive Officer 54 2014-02-12
Director of Finance/CFO 52 2020-03-02
President 49 2024-09-30
Director TitleAgeSince
Chairman 54 2014-02-12
Director/Board Member 59 2015-06-14
Director/Board Member 64 2016-01-07
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Sell

General Counsel

-4,856 0.0194%
9/1/26 Sell

Chief Financial Officer

-6,381 0.0255%
8/31/26 Sell

Chief Financial Officer

-9,307 0.0372%
Change 5-day change 1-year change 3-year change Capi.($)
+1.95%+3.45%+38.53%+67.09% 4.16B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 117B
+0.88%+1.88%+1.66%+36.51% 116B
+1.10%+1.33%-43.61%+6.67% 91.03B
-0.31%-4.72%-3.36%+72.86% 61.89B
-0.32%-0.19%+10.38%+83.80% 55.85B
+0.07%+0.42%+5.94%-22.43% 53.16B
+0.30%+1.70%-11.26%+43.83% 44.35B
+1.01%+0.59%-2.09%-7.88% 33.59B
Average +0.48%+1.20%-4.19%+30.71% 75.43B
Weighted average by Cap. +0.28%+1.26%-12.05%+24.59%

Financials

2026 *2027 *
Net sales 2.19B 1.97B 1.82B 1.65B 3.07B 209B 3.11B 21.73B 8.65B 109B 8.22B 8.05B 347B 2.29B 2.05B 1.9B 1.72B 3.21B 218B 3.25B 22.69B 9.04B 114B 8.59B 8.4B 362B
Net income 90.54M 81.24M 75.11M 68.02M 127M 8.62B 129M 898M 358M 4.51B 340M 333M 14.33B 117M 105M 97.17M 88.01M 164M 11.16B 166M 1.16B 463M 5.84B 440M 430M 18.53B
Net Debt 755M 678M 627M 568M 1.06B 71.95B 1.07B 7.49B 2.98B 37.65B 2.83B 2.77B 120B 569M 510M 472M 427M 798M 54.15B 808M 5.64B 2.25B 28.33B 2.13B 2.09B 89.95B
Projected Income Statement - Annual - ICU Medical, Inc.
Logo ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.
Employees
13,000
Date Price Change Volume
26-10-28 US$166.39 +1.95% 156,445
26-10-27 US$163.20 -1.66% 323,145
26-10-26 US$165.96 -0.40% 155,385
26-10-23 US$166.62 -1.02% 272,324
26-10-22 US$168.33 +4.66% 241,767
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - ICU Medical, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
166.39USD
Average target price
193.38USD
Spread / Average Target
+16.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ICU Medical, Inc.
  1. Stock Market
  2. Stocks
  3. ICUI Stock